Cyp2c9 Variants - Toxicology

Relevant Publications

Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-Analysis.

Issue Release: 2024

Refining Hepatocyte Models to Capture the Impact of CYP2D6*10 Utilizing a PITCh System.

Issue Release: 2024

Deep mutational scanning of CYP2C19 in human cells reveals a substrate specificity-abundance tradeoff.

Issue Release: 2024

The relationship between CYP2C9 gene polymorphisms and azilsartan metabolism in vitro.

Issue Release: 2024

Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease.

Issue Release: 2024

Association between CYP4A11 and EPHX2 genetic polymorphisms and chronic kidney disease progression in hypertensive patients.

Issue Release: 2024

Phenotype-Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism.

Issue Release: 2024

Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients.

Issue Release: 2024

Evidence for sex differences in the impact of cytochrome P450 genotypes on early subjective effects of cannabis.

Issue Release: 2024

Genetic variation of CYP2C9 gene and its correlation with cardiovascular disease risk factors.

Issue Release: 2024

A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data.

Issue Release: 2024

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort.

Issue Release: 2024

When less is more: The association between the expression of polymorphic CYPs and AFB1-induced HCC.

Issue Release: 2024

Patterns of pharmacogenetic variation in nine biogeographic groups.

Issue Release: 2024

Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry.

Issue Release: 2024

Structural and biophysical analysis of cytochrome P450 2C9*14 and *27 variants in complex with losartan.

Issue Release: 2024

In silico investigation of cannabinoids from leaves as a potential anticancer drug to inhibit MAPK-ERK signaling pathway and EMT induction.

Issue Release: 2024

Frequency of pharmacogenomic variants affecting safety and efficacy of immunomodulators and biologics in a South Asian population from Sri Lanka.

Issue Release: 2024

CYP2C19 and CYP2J2 genotypes predict praziquantel plasma exposure among Ethiopian school-aged children.

Issue Release: 2024

Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population.

Issue Release: 2024

What Challenges Do These Tools Face?

How Does Glucose 6 Phosphate Relate to Toxicological Concerns?

How Do These Organizations Conduct Research?

What is the Future of Transparency in Product Ingredients?

What Are the Key Objectives of the WEEE Directive?

How Do Toxicokinetics Influence Toxicity?

How do hormonal fluctuations impact toxicological responses?

What Role Do Regulations Play in Preventing Insults?

What is Human Papillomavirus (HPV)?

How does ECHA ensure compliance and enforcement?

Partnered Content Networks

Relevant Topics